MyPrurigoTeam

Both Dupixent (dupilumab) and Nemluvio (nemolizumab) are FDA-approved biologic injections for prurigo nodularis in adults, but they work in different ways and have different dosing schedules.

Here's a quick comparison:

Dupixent
- Targets IL-4 receptors to reduce inflammation
- Given as an injection every other week (after Show Full Answer

Both Dupixent (dupilumab) and Nemluvio (nemolizumab) are FDA-approved biologic injections for prurigo nodularis in adults, but they work in different ways and have different dosing schedules.

Here's a quick comparison:

Dupixent
- Targets IL-4 receptors to reduce inflammation
- Given as an injection every other week (after a larger initial dose)
- Common side effects: nasal/throat inflammation, eye inflammation, herpes infections, dizziness, muscle pain, diarrhea

Nemluvio
- Targets IL-31, a protein that triggers itch and inflammation
- Given as an injection every four weeks (after an initial dose)
- Comes as a prefilled dual-chamber pen
- Dose depends on body weight
- Common side effects: headache, and certain skin reactions Both carry a rare risk of serious allergic reactions. Since they work differently, one may suit someone better than the other depending on their symptoms and health profile. A dermatologist can help figure out which option makes the most sense.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Treatments

Dupixent

Nemluvio